143 related articles for article (PubMed ID: 9562114)
1. Standardisation of sensitivity tests.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):69-70. PubMed ID: 9562114
[No Abstract] [Full Text] [Related]
2. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
[TBL] [Abstract][Full Text] [Related]
3. Has the time come to discontinue proficiency testing?
Salfinger M; Ahmedov S
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1193. PubMed ID: 19793421
[No Abstract] [Full Text] [Related]
4. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
[No Abstract] [Full Text] [Related]
5. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
[No Abstract] [Full Text] [Related]
6. Drug-resistant tuberculosis in the Philippines.
Rivera AB; Tupasi TE; Balagtas ED; Cardano RC; Baello BQ; Quelapio ID; Villa LA; Pascual LG; Co VM; Mantala MJ
Int J Tuberc Lung Dis; 1999 Jul; 3(7):639. PubMed ID: 10423229
[No Abstract] [Full Text] [Related]
7. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
Int J Tuberc Lung Dis; 1998 Jan; 2(1):72-89. PubMed ID: 9562116
[No Abstract] [Full Text] [Related]
8. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Cubillos-Ruiz A; Von Groll A; Del Portillo P; Portaels F; Palomino JC
J Antimicrob Chemother; 2008 Jan; 61(1):123-7. PubMed ID: 17981833
[TBL] [Abstract][Full Text] [Related]
9. New generation methods for drug susceptibility testing for tuberculosis.
Katoch VM
Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
[No Abstract] [Full Text] [Related]
10. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
11. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
[No Abstract] [Full Text] [Related]
12. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
Mitarai S;
Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
[TBL] [Abstract][Full Text] [Related]
14. [The urgency of developing new technologies to detect drug resistance in Mycobacterium tuberculosis].
Zheng RJ; Hu ZY
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):6-8. PubMed ID: 21418810
[No Abstract] [Full Text] [Related]
15. The "source" of drug-resistant TB outbreaks.
van Helden PD; Victor T; Warren RM
Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
[No Abstract] [Full Text] [Related]
16. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
Pavlov EP
Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
[No Abstract] [Full Text] [Related]
17. External quality assurance of drug susceptibility testing in the southern African development community.
Mativandlela SP; Brand J; Matlhola N; Sewpersadh M; Olorunju SA; van der Walt ML
Int J Tuberc Lung Dis; 2013 Mar; 17(3):425. PubMed ID: 23407237
[No Abstract] [Full Text] [Related]
18. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
Iavors'ka HV; Puhachevs'ka LP
Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
[TBL] [Abstract][Full Text] [Related]
19. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Long R; Scalcini M
Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879
[No Abstract] [Full Text] [Related]
20. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
